InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the complete record of transactions filed by Berry David A, 董事. Director active across 1 company, notably Omega Therapeutics, Inc.. Aggregated, 1 disclosures have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €760k. Activity tracked since 3 August 2021. The latest transaction was filed on 3 August 2021 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 条申报中的 1 条
David A. Berry is a Board Member of Omega Therapeutics, Inc. In this role, he contributes to the governance of the company and strategic decision-making. His expertise in the biopharmaceutical sector allows him to provide valuable advice to the board. He is committed to supporting the objectives of Omega Therapeutics.